To characterize CAFs, the expression of selected markers, such as α-SMA, vimentin, S100A4, CD90, CD73 and CD105, has been used [28], and up to 14 subpopulations of immunostimulatory CAFs have been identified in HNSCC [29]. The gene discussed is THY1; the disease is head and neck squamous cell carcinoma.